{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:15:49Z","timestamp":1790867749947,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.vaccine.2008.10.089","type":"journal-article","created":{"date-parts":[[2008,11,26]],"date-time":"2008-11-26T13:22:53Z","timestamp":1227705773000},"page":"378-387","source":"Crossref","is-referenced-by-count":69,"title":["Leptospira immunoglobulin-like protein A variable region (LigAvar) incorporated in liposomes and PLGA microspheres produces a robust immune response correlating to protective immunity"],"prefix":"10.1016","volume":"27","author":[{"given":"Syed M.","family":"Faisal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WeiWei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean P.","family":"McDonough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Fu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.vaccine.2008.10.089_bib1","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1473-3099(03)00830-2","article-title":"Leptospirosis: a zoonotic disease of global importance","volume":"3","author":"Bharti","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2008.10.089_bib2","series-title":"Leptospira and leptospirosis","year":"1999"},{"issue":"6","key":"10.1016\/j.vaccine.2008.10.089_bib3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/vr.153.6.165","article-title":"Comparison of the efficacy of three commercial bacterins in preventing canine leptospirosis","volume":"153","author":"Andre-Fontaine","year":"2003","journal-title":"Vet Rec"},{"issue":"5","key":"10.1016\/j.vaccine.2008.10.089_bib4","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.medmal.2004.02.006","article-title":"Efficacy of Spirolept vaccine against human leptospirosis as estimated by passive protection of laboratory rodents","volume":"34","author":"Rodriguez-Gonzalez","year":"2004","journal-title":"Med Mal Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2008.10.089_bib5","first-page":"73","article-title":"An immunoprotective monoclonal antibody directed against Leptospira interrogans serovar Copenhageni","volume":"135","author":"Schoone","year":"1989","journal-title":"J Gen Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.10.089_bib6","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.4049\/jimmunol.171.3.1447","article-title":"Leptospira interrogans activation of human peripheral blood mononuclear cells: preferential expansion of TCR gamma delta+ T cells vs TCR alpha beta+ T cells","volume":"171","author":"Klimpel","year":"2003","journal-title":"J Immunol"},{"issue":"3\/4","key":"10.1016\/j.vaccine.2008.10.089_bib7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0165-2427(02)00091-0","article-title":"Activation of bovine peripheral blood gammadelta T cells for cell division and IFN-gamma production","volume":"87","author":"Baldwin","year":"2002","journal-title":"Vet Immunol Immunopathol"},{"issue":"12","key":"10.1016\/j.vaccine.2008.10.089_bib8","doi-asserted-by":"crossref","first-page":"7550","DOI":"10.1128\/IAI.69.12.7550-7558.2001","article-title":"Protective killed Leptospira borgpetersenii vaccine induces potent Th1 immunity comprising responses by CD4 and gammadelta T lymphocytes","volume":"69","author":"Naiman","year":"2001","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2008.10.089_bib9","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1128\/IAI.73.7.4062-4069.2005","article-title":"Protection against Leptospira interrogans sensu lato challenge by DNA immunization with the gene encoding hemolysin-associated protein 1","volume":"73","author":"Branger","year":"2005","journal-title":"Infect Immun"},{"issue":"48","key":"10.1016\/j.vaccine.2008.10.089_bib10","doi-asserted-by":"crossref","first-page":"8190","DOI":"10.1016\/j.vaccine.2007.09.020","article-title":"Immunogenicity of the recombinant leptospiral putative outer membrane proteins as vaccine candidates","volume":"25","author":"Chang","year":"2007","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2008.10.089_bib11","doi-asserted-by":"crossref","first-page":"6572","DOI":"10.1128\/IAI.67.12.6572-6582.1999","article-title":"Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection","volume":"67","author":"Haake","year":"1999","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2008.10.089_bib12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.vaccine.2007.10.052","article-title":"Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge","volume":"26","author":"Seixas","year":"2007","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2008.10.089_bib13","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1046\/j.1365-2958.2003.03619.x","article-title":"Pathogenic Leptospira species express surface-exposed proteins belonging to the bacterial immunoglobulin superfamily","volume":"49","author":"Matsunaga","year":"2003","journal-title":"Mol Microbiol"},{"issue":"Part 10","key":"10.1016\/j.vaccine.2008.10.089_bib14","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1099\/jmm.0.45568-0","article-title":"Expression of leptospiral immunoglobulin-like protein by Leptospira interrogans and evaluation of its diagnostic potential in a kinetic ELISA","volume":"53","author":"Palaniappan","year":"2004","journal-title":"J Med Microbiol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.10.089_bib15","doi-asserted-by":"crossref","first-page":"5924","DOI":"10.1128\/IAI.70.11.5924-5930.2002","article-title":"Cloning and molecular characterization of an immunogenic LigA protein of Leptospira interrogans","volume":"70","author":"Palaniappan","year":"2002","journal-title":"Infect Immun"},{"issue":"20","key":"10.1016\/j.vaccine.2008.10.089_bib16","doi-asserted-by":"crossref","first-page":"7839","DOI":"10.1073\/pnas.87.20.7839","article-title":"A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells","volume":"87","author":"Jerse","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"issue":"16","key":"10.1016\/j.vaccine.2008.10.089_bib17","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1128\/JB.183.16.4823-4838.2001","article-title":"Genome sequence and comparative analysis of the solvent-producing bacterium Clostridium acetobutylicum","volume":"183","author":"Nolling","year":"2001","journal-title":"J Bacteriol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.10.089_bib18","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0092-8674(87)90335-7","article-title":"Identification of invasin: a protein that allows enteric bacteria to penetrate cultured mammalian cells","volume":"50","author":"Isberg","year":"1987","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.vaccine.2008.10.089_bib19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.vaccine.2007.10.029","article-title":"Evaluation of protective immunity of Leptospira immunoglobulin like protein A (LigA) DNA vaccine against challenge in hamsters","volume":"26","author":"Faisal","year":"2008","journal-title":"Vaccine"},{"issue":"11\/12","key":"10.1016\/j.vaccine.2008.10.089_bib20","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.vaccine.2003.10.007","article-title":"Leptospiral immunoglobulin-like proteins elicit protective immunity","volume":"22","author":"Koizumi","year":"2004","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2008.10.089_bib21","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1128\/IAI.74.3.1745-1750.2006","article-title":"Immunoprotection of recombinant leptospiral immunoglobulin-like protein A against Leptospira interrogans serovar Pomona infection","volume":"74","author":"Palaniappan","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2008.10.089_bib22","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.1016\/j.vaccine.2007.05.053","article-title":"The terminal portion of leptospiral immunoglobulin-like protien A confers protective immunity against lethal infection in the hamster model of leptospirosis","volume":"25","author":"Silva","year":"2007","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2008.10.089_bib23","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0958-1669(05)80126-0","article-title":"Recombinant subunit vaccines","volume":"2","author":"Burnette","year":"1991","journal-title":"Curr Opin Biotechnol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.10.089_bib24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0264-410X(93)90190-9","article-title":"Adjuvants\u2014a balance between toxicity and adjuvanticity","volume":"11","author":"Gupta","year":"1993","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2008.10.089_bib25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0169-409X(98)00008-8","article-title":"Aluminum compounds as vaccine adjuvants","volume":"32","author":"Gupta","year":"1998","journal-title":"Adv Drug Deliv Rev"},{"issue":"9\/10","key":"10.1016\/j.vaccine.2008.10.089_bib26","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0264-410X(97)00288-0","article-title":"Rational approaches to reduce adverse reactions in man to vaccines containing tetanus and diphtheria toxoids","volume":"16","author":"Relyveld","year":"1998","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.vaccine.2008.10.089_bib27","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/0264-410X(95)00107-C","article-title":"Isolation and quantification of Quillaja saponaria Molina saponins and lipids in iscom-matrix and iscoms","volume":"13","author":"Behboudi","year":"1995","journal-title":"Vaccine"},{"issue":"11\/12","key":"10.1016\/j.vaccine.2008.10.089_bib28","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0264-410X(98)00361-2","article-title":"Immunogenicity of IRIV- versus alum-adjuvanted diphtheria and tetanus toxoid vaccines in influenza primed mice","volume":"17","author":"Zurbriggen","year":"1999","journal-title":"Vaccine"},{"issue":"3\/4","key":"10.1016\/j.vaccine.2008.10.089_bib29","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0304-4157(92)90004-T","article-title":"Immunologic aspects of liposomes: presentation and processing of liposomal protein and phospholipid antigens","volume":"1113","author":"Alving","year":"1992","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.vaccine.2008.10.089_bib30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0167-5699(90)90034-7","article-title":"Immunological adjuvants: a role for liposomes","volume":"11","author":"Gregoriadis","year":"1990","journal-title":"Immunol Today"},{"issue":"18","key":"10.1016\/j.vaccine.2008.10.089_bib31","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1016\/j.vaccine.2007.01.066","article-title":"Liposomised recombinant ribosomal L7\/L12 protein protects BALB\/c mice against Brucella abortus 544 infection","volume":"25","author":"Mallick","year":"2007","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2008.10.089_bib32","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1128\/iai.30.3.728-733.1980","article-title":"Humoral and cellular immunity to hepatitis B virus-derived antigens: comparative activity of Freund complete adjuvant alum, and liposomes","volume":"30","author":"Sanchez","year":"1980","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2008.10.089_bib33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nbt0298-153","article-title":"Improving protein therapeutics with sustained-release formulations","volume":"16","author":"Putney","year":"1998","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.10.089_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v12.i1.10","article-title":"Biodegradable microspheres in drug delivery","volume":"12","author":"Okada","year":"1995","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"issue":"3","key":"10.1016\/j.vaccine.2008.10.089_bib35","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0161-5890(91)90076-V","article-title":"Biodegradable microspheres as a vaccine delivery system","volume":"28","author":"Eldridge","year":"1991","journal-title":"Mol Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.10.089_bib36","first-page":"239","article-title":"Biodegradable microparticles as controlled release antigen delivery systems","volume":"73","author":"O\u2019Hagan","year":"1991","journal-title":"Immunology"},{"issue":"10","key":"10.1016\/j.vaccine.2008.10.089_bib37","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/0264-410X(91)90295-H","article-title":"Controlled release microparticles for vaccine development","volume":"9","author":"O\u2019Hagan","year":"1991","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.vaccine.2008.10.089_bib38","doi-asserted-by":"crossref","first-page":"8189","DOI":"10.1128\/JVI.79.13.8189-8200.2005","article-title":"Enhanced potency of plasmid DNA microparticle human immunodeficiency virus vaccines in rhesus macaques by using a priming-boosting regimen with recombinant proteins","volume":"79","author":"Otten","year":"2005","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.10.089_bib39","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1023\/A:1018980020506","article-title":"The preparation and characterization of poly(lactide-co-glycolide) microparticles. II. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique","volume":"10","author":"Jeffery","year":"1993","journal-title":"Pharm Res"},{"issue":"1","key":"10.1016\/j.vaccine.2008.10.089_bib40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2006.01.012","article-title":"Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres","volume":"112","author":"Feng","year":"2006","journal-title":"J Control Release"},{"issue":"10","key":"10.1016\/j.vaccine.2008.10.089_bib41","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1211\/0022357044418","article-title":"Development of a single-dose stabilized poly(d,l-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B","volume":"56","author":"Jaganathan","year":"2004","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.10.089_bib42","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/02652048409031535","article-title":"Preparation of liposomes containing factor VIII for oral treatment of haemophilia","volume":"1","author":"Kirby","year":"1984","journal-title":"J Microencapsul"},{"issue":"19\/20","key":"10.1016\/j.vaccine.2008.10.089_bib43","first-page":"2383","article-title":"Antigen entrapped in the escheriosomes leads to the generation of CD4(+) helper and CD8(+) cytotoxic T cell response","volume":"21","author":"Faisal","year":"2003","journal-title":"Vaccine"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2008.10.089_bib44","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0171-2985(11)80470-5","article-title":"Controlled-release vaccines\u2014biodegradable polylactide\/polyglycolide (PL\/PG) microspheres as antigen vehicles","volume":"184","author":"Aguado","year":"1992","journal-title":"Immunobiology"},{"issue":"6","key":"10.1016\/j.vaccine.2008.10.089_bib45","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3109\/02652049809008253","article-title":"Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues","volume":"15","author":"Crotts","year":"1998","journal-title":"J Microencapsul"},{"issue":"10","key":"10.1016\/j.vaccine.2008.10.089_bib46","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1023\/A:1026498209874","article-title":"Protein instability in poly(lactic-co-glycolic acid) microparticles","volume":"17","author":"van de Weert","year":"2000","journal-title":"Pharm Res"},{"issue":"9","key":"10.1016\/j.vaccine.2008.10.089_bib47","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1128\/IAI.59.9.2978-2986.1991","article-title":"Biodegradable and biocompatible poly(dl-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies","volume":"59","author":"Eldridge","year":"1991","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2008.10.089_bib48","first-page":"59","article-title":"Antigen incorporation into liposomes results in the enhancement of IL-4 and IgG1 secretion: evidence for preferential expansion of Th-2 cells","volume":"2","author":"Agrewala","year":"1996","journal-title":"Cytokines Mol Ther"},{"issue":"2","key":"10.1016\/j.vaccine.2008.10.089_bib49","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1084\/jem.168.2.543","article-title":"Lymphokine-mediated regulation of the proliferative response of clones of T helper 1 and T helper 2 cells","volume":"168","author":"Fernandez-Botran","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2008.10.089_bib50","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","article-title":"TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties","volume":"7","author":"Mosmann","year":"1989","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.10.089_bib51","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1128\/IAI.01635-06","article-title":"Physiological osmotic induction of Leptospira interrogans adhesion: LigA and LigB bind extracellular matrix proteins and fibrinogen","volume":"75","author":"Choy","year":"2007","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2008.10.089_bib52","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.bbrc.2007.07.196","article-title":"A domain of the Leptospira LigB contributes to high affinity binding of fibronectin","volume":"362","author":"Lin","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2008.10.089_bib53","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4142\/jvs.2008.9.2.133","article-title":"The C-terminal variable domain of LigB from Leptospira mediates binding to fibronectin","volume":"9","author":"Lin","year":"2008","journal-title":"J Vet Sci"},{"issue":"37","key":"10.1016\/j.vaccine.2008.10.089_bib54","doi-asserted-by":"crossref","first-page":"25140","DOI":"10.1074\/jbc.M801350200","article-title":"Calcium binds to Leptospiral immunoglobulin-like protein, LigB and modulates fibronectin binding","volume":"283","author":"Lin","year":"2008","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.vaccine.2008.10.089_bib55","doi-asserted-by":"crossref","first-page":"6926","DOI":"10.1128\/IAI.70.12.6926-6932.2002","article-title":"Rapid translocation of polarized MDCK cell monolayers by Leptospira interrogans, an invasive but nonintracellular pathogen","volume":"70","author":"Barocchi","year":"2002","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2008.10.089_bib56","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1128\/IAI.65.2.729-738.1997","article-title":"Invasion of Vero cells and induction of apoptosis in macrophages by pathogenic Leptospira interrogans are correlated with virulence","volume":"65","author":"Merien","year":"1997","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08015041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08015041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T06:57:41Z","timestamp":1632380261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08015041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0264410X08015041"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.10.089","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}